5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells
Keyword(s):
2019 ◽
Vol 47
(3)
◽
pp. 503-516
2017 ◽
Vol 17
(1)
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 15
(2)
◽
pp. 724-730
◽